AMSilk has appointed Christian Wichert as its new chief executive officer as the biomaterials company moves to scale up and commercialize its silk protein technology. Wichert brings over 25 years of international leadership experience, most recently serving as CEO of Swiss biotech firm Evolva, where he oversaw strategic changes and its sale to Danstar Ferment AG/Lallemand Group. He will focus on boosting commercial operations and expanding the reach of AMSilk's precision fermentation-based silk proteins, with particular emphasis on the Consumer Care Solutions division. Ulrich Scherbel, who previously led the company through technology development and initial commercialization, will remain as managing director and take on the role of chief operating officer for premium filaments.
Evolva Holding SAFormer CEO of Evolva, but no direct impact on Evolva mentioned; only context for his background.
New CEO appointed to scale up and commercialize silk protein technology, focusing on commercial operations.